Skip to content
10-Q

Quarterly Report

PANDION THERAPEUTICS, INC.

0001564590-20-054183

← back to feed
Filed
Nov 16, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2020 · Nov 12, 2020 29.52M sh
Capex Q3 2020 · Sep 30, 2020 $2.01M
Capex Q3 2020 · Sep 30, 2019 $437K
Operating Cash Flow Q3 2020 · Sep 30, 2020 −$23.82M
Operating Cash Flow Q3 2020 · Sep 30, 2019 −$16.31M
Cash And Equivalents Q3 2020 · Sep 30, 2020 $232.32M
Cash And Equivalents Q3 2020 · Dec 31, 2019 $15.97M
Cash And Equivalents Q3 2020 · Sep 30, 2019 $11.39M
Current Liabilities Q3 2020 · Sep 30, 2020 $11.69M
Current Liabilities Q3 2020 · Dec 31, 2019 $7.03M
Total Liabilities Q3 2020 · Sep 30, 2020 $16.12M
Total Liabilities Q3 2020 · Dec 31, 2019 $16.84M
Current Assets Q3 2020 · Sep 30, 2020 $237.44M
Current Assets Q3 2020 · Dec 31, 2019 $19.97M
Total Assets Q3 2020 · Sep 30, 2020 $240.96M
Total Assets Q3 2020 · Dec 31, 2019 $21.02M
Sga Expense Q3 2020 · Sep 30, 2020 $4.34M
Sga Expense Q3 2020 · Sep 30, 2020 $8.2M
Sga Expense Q3 2020 · Sep 30, 2019 $1.52M
Sga Expense Q3 2020 · Sep 30, 2019 $3.14M
Rd Expense Q3 2020 · Sep 30, 2020 $9.29M
Rd Expense Q3 2020 · Sep 30, 2020 $25.09M
Rd Expense Q3 2020 · Sep 30, 2019 $4.39M
Rd Expense Q3 2020 · Sep 30, 2019 $14.41M
Net Income Q3 2020 · Sep 30, 2020 −$11.23M
Net Income Q3 2020 · Sep 30, 2020 −$26.89M
Net Income Q3 2020 · Sep 30, 2019 −$5.85M
Net Income Q3 2020 · Sep 30, 2019 −$17.33M
Operating Income Q3 2020 · Sep 30, 2020 −$10.99M
Operating Income Q3 2020 · Sep 30, 2020 −$26.7M
Operating Income Q3 2020 · Sep 30, 2019 −$5.91M
Operating Income Q3 2020 · Sep 30, 2019 −$17.54M
Revenue Q3 2020 · Sep 30, 2020 $2.63M
Revenue Q3 2020 · Sep 30, 2020 $6.59M